CLC bio AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

CLC bio A/S (CLC), a subsidiary of Qiagen N.V., is a bio-informatics software company that designs and develops comprehensive computing solutions and user-friendly analysis packages for analyzing, comparing, and visualizing next generation sequencing data. Its analysis platform integrates desktop and server software and optimizes them for better performance. The companys analyses are available in graphical interface and command-line formats. CLCs product portfolio comprises of desktop software, enterprise software, genomics machines and microbial genome finishing modules. It offers consultation services such as customization, integration, scientific applications and customer projects and also provides support services including documentation and training. The company has operations in India, Japan, Denmark, Taiwan, and the US. CLC is headquartered in Aarhus, Denmark.

CLC bio AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.




BioClinica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioClinica Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BioClinica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioClinica Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
BioClinica Inc, Medical Devices Deals, 2011 to YTD 2017 9
BioClinica Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
BioClinica Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Clinverse Raises USD9 Million in Series C Venture Financing 11
Clinverse Raises US$3.8 Million In Series B Financing 12
Partnerships 13
BioClinica Enters Into Agreement With NNIT For Clinical Trial Management System 13
Symbiance Enters Into Agreement With BioClinica 14
Merger 15
CCBR-Synarc And BioClinica Complete Merger 15
Licensing Agreements 16
BioClinica Enters Into Licensing Agreement With Grunenthal For BioClinica OnPoint CTMS 16
Acquisition 17
BioClinica Acquires Compass Research 17
Bioclinica Acquires Clinverse 18
BioClinica Acquires Synowledge 19
BioClinica Inc - Key Competitors 20
BioClinica Inc - Key Employees 21
BioClinica Inc - Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 25
Strategy And Business Planning 25
Oct 02, 2017: Bioclinica: New Jersey Lt. Governor Kim Guadagno, clients, partners, attend open house 25
Corporate Communications 26
Jan 18, 2017: Bioclinica Medical Imaging Biomarkers Announces Pivotal Hires 26
Product News 27
Jun 22, 2016: Bioclinica eHealth Solutions Launches Safety and Regulatory Software Products 27
May 25, 2016: Bioclinica launches OnPoint Direct 28
Feb 21, 2017: Bioclinica Announces New eHealth App xChange Partners, Driving Industry Collaboration 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List Of Tables


BioClinica Inc, Pharmaceuticals & Healthcare, Key Facts 2
BioClinica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioClinica Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BioClinica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioClinica Inc, Deals By Therapy Area, 2011 to YTD 2017 8
BioClinica Inc, Medical Devices Deals, 2011 to YTD 2017 9
BioClinica Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Clinverse Raises USD9 Million in Series C Venture Financing 11
Clinverse Raises US$3.8 Million In Series B Financing 12
BioClinica Enters Into Agreement With NNIT For Clinical Trial Management System 13
Symbiance Enters Into Agreement With BioClinica 14
CCBR-Synarc And BioClinica Complete Merger 15
BioClinica Enters Into Licensing Agreement With Grunenthal For BioClinica OnPoint CTMS 16
BioClinica Acquires Compass Research 17
Bioclinica Acquires Clinverse 18
BioClinica Acquires Synowledge 19
BioClinica Inc, Key Competitors 20
BioClinica Inc, Key Employees 21
BioClinica Inc, Other Locations 23
BioClinica Inc, Subsidiaries 24

List Of Figures


BioClinica Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
BioClinica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
BioClinica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
BioClinica Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
BioClinica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioClinica Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
BioClinica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioClinica Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
BioClinica Inc, Medical Devices Deals, 2011 to YTD 2017 9

Non-Small Cell Lung Cancer (NSCLC) - Dynamic Market Forecast to 2025

The NSCLC therapeutics market is a rapidly evolving field in which new developments are constantly influencing the landscape.

USD 8495 View Report

CoLucid Pharmaceuticals Inc (CLCD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

CoLucid Pharmaceuticals Inc (CoLucid) is a pharmaceutical company that conducts research and develops new therapies. CoLucids lead product candidate Lasmiditan (COL-144), is an oral tablet that penetrates the central nervous

USD 250 View Report

CLC bio AS - Strategic SWOT Analysis Review

CLC bio AS - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

BerGenBio AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

BerGenBio AS (BerGenBio) is a biotechnology company that develops drugs for aggressive and drug resistant cancers. The company develops epithelial-mesenchymal transition (EMT) inhibitors for acquired cancer drug-resistance and metastasis. The

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available